“I am a biotech and pharma scientist, and I worked on metabolomics platform development and application since year 2000. biocrates is one of the few companies providing a standardized and validated large-scale metabolomics analysis that generates consistently reproducible data. I came to biocrates for its in-depth coverage of metabolism pathways and highly accurate quantitation via a targeted approach.

Most recently, to investigate the mode of action (MoA) of a research drug candidate, I used the Quant 500 XL platform that quantifies small molecules of critical metabolism pathways and a large number of lipids. With this comprehensive panel and accurate quantitation, I was able to obtain great insights into metabolic processes and pathways perturbed by our molecule. biocrates’ team of experts is highly professional, the analytical team is meticulous and knowledgeable about their workflow from sample prep to data analysis. The data analysis solutions brought me the efficiency and enabled me to focus on result interpretation for my research program. I am confident in continuing work with the biocrates team for my discoveries in future studies.”